Table 2.
IBD characteristics.
| IBD patients with prior CDI (n = 43) | IBD patients without prior CDI (n = 611) | Univariate analysis | |
|---|---|---|---|
| p value | |||
| ≥1 IBD-related hospitalization, n (%) | 32 (72) | 255 (41.7) | p < 0.001 |
| Number of IBD-related hospitalizations, mean ± SD | 2.9 ± 3.1 | 1.12 ± 2.27 | p < 0.001 |
| Surgery for IBD, n (%) | 19 (43.2) | 205 (33.5) | p = 0.150 |
| Biologic as peak IBD therapy, n (%) | 25 (56.8) | 231 (37.8) | p = 0.008 |
| Salicylate as peak IBD therapy, n (%) | 8 (18) | 189 (30.9) | p = 0.088 |
| Extraintestinal manifestations of IBD, n (%) | 19 (43) | 174 (28.4) | p = 0.021 |
| Lowest albumin, mean ± SD | 2.98 ± 0.83 | 3.45 ± 0.79 | p < 0.001 |
| Peak CRP, mean ± SD | 55.9 ± 64.8 | 37.8 ± 58.3 | p = 0.065 |
| Peak ESR, mean ± SD | 43.5 ± 31.5 | 35 ± 28.2 | p = 0.071 |
CRP = C-reactive protein, ESR = erythrocyte sedimentation rate.